MiRNA-488-3p inhibits malignant progression of NSCLC by modulating ADAM9.
Sign Up to like & getrecommendations! Published in 2021 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_202104_25533
Abstract: Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "MiRNA-488-3p inhibits malignant progression of NSCLC by modulating ADAM9,… read more here.
Keywords: mirna 488; inhibits malignant; malignant progression; nsclc modulating ... See more keywords